CPRX FY 2023 Earnings — Catalyst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

CPRXCatalyst Pharmaceuticals, Inc.

$3B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$398M+85.9% YoY

Gross Profit

$346M86.9% margin

Operating Income

$87M21.8% margin

Net Income

$71M17.9% margin

EPS (Diluted)

$0.63

Cash Flow

Operating Cash Flow

$144M

Free Cash Flow

$62M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$470M

Total Liabilities

$82M

Stockholders' Equity

$388M

Cash & Equivalents

$138M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$398M	$214M	+85.9%
Gross Profit	$346M	$180M	+92.6%
Operating Income	$87M	$102M	-14.8%
Net Income	$71M	$83M	-14.0%